UK markets closed

Nordicus Partners Corporation (NORD)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.61000.0000 (0.00%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.6100
Open0.6100
BidN/A x N/A
AskN/A x N/A
Day's range0.6100 - 0.6100
52-week range0.4500 - 0.9500
Volume1
Avg. volume195
Market cap6.729M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.2500
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK

    Beverly Hills, California., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, today announced it entered into a paying Consultancy Agreement with Orocidin A/S in Denmark. Orocidin A/S (“Orocidin”) is a clinical-stage biopharmaceutical company focused on the discovery, deve